ASTRA MERCK, ABBOTT TO BEGIN SEPARATE CAMPAIGNS FOR BIAXIN/PRILOSEC COMBO FOR HELICOBACTER PYLORI ERADICATION; COST-EFFECTIVENESS MAY HINGE ON COMPLIANCE
Executive Summary
Astra Merck and Abbott will launch separate promotional campaigns for the combination of Prilosec (omeprazole) and Biaxin (clarithromycin) for treatment of Helicobacter pylori-associated duodenal ulcers.